Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania

BACKGROUND: Tanzania adopted artemether-lumefantrine (AL) as first-line drug for uncomplicated malaria in 2006. Recently, there was an anecdotal report on high malaria recurrence rate following AL treatment in in the (urban and peri-urban), western part of Tanzania. The current report is an explorat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Joseph, Deokary, Kabanywanyi, Abdunoor M, Hulser, Ruth, Premji, Zulfiqarali, Minzi, Omary MS, Mugittu, Kefas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637145/
https://ncbi.nlm.nih.gov/pubmed/23399782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-60
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak